The cortisol response to exercise in young adults by Henning eBudde, Henning eBudde, Sergio eMachado, Pedro eRibeiro, Mirko eWegner

Get full text

ON THE DEVELOPMENT OF A DATASET PUBLICATION GUIDELINE: DATA REPOSITORIES AND KEYWORD ANALYSIS IN ISPRS DOMAIN by L. E. Budde, T. Kullmann, D. Iwaszczuk

Get full text

Automated Fault Tree Learning from Continuous-valued Sensor Data: A Case Study on Domestic Heaters by Bart Verkuil, Carlos E. Budde, Doina Bucur

Get full text

IDENTIFICATION OF MISCLASSIFIED PIXELS IN SEMANTIC SEGMENTATION WITH UNCERTAINTY EVALUATION by L. E. Budde, D. Bulatov, D. Iwaszczuk

Get full text

CURRENT STATUS OF THE BENCHMARK DATABASE BEMEDA by L. E. Budde, J. Schmidt, T. Kullmann, D. Iwaszczuk

Get full text

Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting by Yang Cao, Emanuela C. Marcucci, Lihua E. Budde

Get full text

Revolutionizing genetic disease treatment: The case of exagamglogene autotemcel by Shuquan Rao, Yao Yao, Wenxuan Huo, Yang Cao, Lihua E. Budde

Get full text

DEVELOPMENT OF A DATABASE FOR BENCHMARK DATASETS IN PHOTOGRAMMETRY AND REMOTE SENSING by L. E. Budde, J. Schmidt, A. Javanmard-Ghareshiran, S. Hunger, D. Iwaszczuk

Get full text

CSEC+ framework assessment dataset: Expert evaluations of cybersecurity skills for job profiles in Europe by Carlos E. Budde, Anni Karinsalo, Silvia Vidor, Jarno Salonen, Fabio Massacci

Get full text

Limbic encephalitis: Potential impact of adaptive autoimmune inflammation on neuronal circuits of the amygdala by Nico eMelzer, Thomas eBudde, Oliver eStork, Sven G Meuth

Get full text

CD8+ T cell-mediated neuronal dysfunction and degeneration in limbic encephalitis by Petra eEhling, Petra eEhling, Nico eMelzer, Thomas eBudde, Sven G Meuth, Sven G Meuth

Get full text

Normalized Difference Vegetation Index as an Estimator for Abundance and Quality of Avian Herbivore Forage in Arctic Alaska by Kyle R. Hogrefe, Vijay P. Patil, Daniel R. Ruthrauff, Brandt W. Meixell, Michael E. Budde, Jerry W. Hupp, David H. Ward

Get full text

P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14... by P. Strati, L. Leslie, P. Shiraz, E. Budde, O. O. Oluwole, M. Ulrickson, A. Ramakrishnan, J. Sun, R. Shen, J. Kanska, P. McCroskery, J. Dong, M. Schupp, H. Xu, K. Patel

Get full text

Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma. by Lihua E Budde, Carolina Berger, Yukang Lin, Jinjuan Wang, Xubin Lin, Shani E Frayo, Shaunda A Brouns, David M Spencer, Brian G Till, Michael C Jensen, Stanley R Riddell, Oliver W Press

Get full text

P1124: MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA by C. Y. Cheah, N. L. Bartlett, S. Assouline, S. J. Schuster, W. Seog Kim, M. Shadman, I. Isufi, S. Yin, M. Y. Doral, J. Sit, V. Chen, H. Huang, M. Zhou, M. C. Wei, L. E. Budde

Get full text

Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma by Colton Ladbury, Savita Dandapani, Claire Hao, Mildred Fabros, Arya Amini, Sagus Sampath, Scott Glaser, Karen Sokolov, Jekwon Yeh, John H. Baird, Swetha Kambhampati, Alex Herrera, Matthew Mei, Liana Nikolaenko, Geoffrey Shouse, Lihua E. Budde

Get full text

P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF... by M. Matasar, N. L. Bartlett, L. H. Sehn, S. J. Schuster, S. Assouline, P. Giri, J. Kuruvilla, M. Canales, S. Dietrich, K. Fay, M. Ku, L. J. Nastoupil, M. C. Wei, S. Yin, I. To, D. Turner, H. Huang, J. Min, E. Penuel, L. E. Budde

Get full text

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma by Surbhi Sidana, Hitomi Hosoya, Alexandria Jensen, Lawrence Liu, Anmol Goyal, Vanna Hovanky, Bita Sahaf, Sushma Bharadwaj, Theresa Latchford, Sally Arai, Sheryl Leahy, Matthew Mei, Lihua E. Budde, Lori S. Muffly, Matthew J. Frank, Saurabh Dahiya, Myo Htut, David Miklos, Murali Janakiram

Get full text

P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US) by F. Locke, MD, Z.-H. Hu, MPH, J. Gerson, MD, M. J. Frank, PhD, L. E. Budde, PhD, M. Wang, MD, B. Logan, PhD, I. Kloos, PhD, R. Siddiqi, PhD, J. Shah, MD, H. Xu, PhD, M. Pasquini, MS

Get full text

P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA by M. K. Leabman, G. Hernandez, C. M. Ng, J. Tang, D. Pandya, K. C. Hart, K. Li, P. R. Hinton, J. So, I. Qazi, C. Y. Cheah, W. S. Kim, E. Budde, A. K. Gopal, T. Manley, C. H. Takimoto, A. M. Sinclair, S. F. Carroll, B. A. Keyt, M. F. Kotturi

Get full text